CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis
Keywords:
Liver cancer
Objective response
Overall survival
Checkpoint inhibitors
Anti-PD-1
Immunotherapy
Liver decompensation
Note:
This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Citation:
Kudo, M. (Masatoshi); Matilla, A. (Ana); Santoro, A. (Armando); et al. "CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis". Journal of Hepatology. 75 (3), 2021, 600 - 609
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.